These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 37127834)
21. The circadian gene, Per2, influences methamphetamine sensitization and reward through the dopaminergic system in the striatum of mice. Kim M; Custodio RJ; Botanas CJ; de la Peña JB; Sayson LV; Abiero A; Ryoo ZY; Cheong JH; Kim HJ Addict Biol; 2019 Sep; 24(5):946-957. PubMed ID: 30091820 [TBL] [Abstract][Full Text] [Related]
22. Hypocretin/orexin system in the nucleus accumbens as a promising player in the extinction and reinstatement of methamphetamine-induced CPP. Amirteymori H; Karimi-Haghighi S; Mirmohammadi M; Majidinezhad M; Khosrowabadi E; Haghparast A Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110616. PubMed ID: 35988849 [TBL] [Abstract][Full Text] [Related]
23. Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region. Hassanlou AA; Jamali S; RayatSanati K; Mousavi Z; Haghparast A Brain Res Bull; 2021 Jul; 172():43-51. PubMed ID: 33862125 [TBL] [Abstract][Full Text] [Related]
24. The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats. Gehrke BJ; Harrod SB; Cass WA; Bardo MT Psychopharmacology (Berl); 2003 Mar; 166(3):249-57. PubMed ID: 12589519 [TBL] [Abstract][Full Text] [Related]
25. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens. Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348 [TBL] [Abstract][Full Text] [Related]
26. Effect of a 5-HT Shahidi S; Komaki A; Sadeghian R; Soleimani Asl S Brain Res; 2018 Nov; 1698():151-160. PubMed ID: 30076792 [TBL] [Abstract][Full Text] [Related]
27. Concurrent exposure to methamphetamine and sexual behavior enhances subsequent drug reward and causes compulsive sexual behavior in male rats. Frohmader KS; Lehman MN; Laviolette SR; Coolen LM J Neurosci; 2011 Nov; 31(45):16473-82. PubMed ID: 22072697 [TBL] [Abstract][Full Text] [Related]
28. Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity. Lohr KM; Stout KA; Dunn AR; Wang M; Salahpour A; Guillot TS; Miller GW ACS Chem Neurosci; 2015 May; 6(5):790-9. PubMed ID: 25746685 [TBL] [Abstract][Full Text] [Related]
29. Cannabidiol enhanced the development of sensitization to the expression of methamphetamine-induced conditioned place preference in male rats. Khanegheini A; Khani M; Zarrabian S; Yousefzadeh-Chabok S; Taleghani BK; Haghparast A J Psychiatr Res; 2021 May; 137():260-265. PubMed ID: 33725638 [TBL] [Abstract][Full Text] [Related]
30. Levo-tetrahydropalmatine attenuates methamphetamine reward behavior and the accompanying activation of ERK phosphorylation in mice. Su H; Sun T; Wang X; Du Y; Zhao N; Zhu J; Yan J; Chen T; Yun K Neurosci Lett; 2020 Jan; 714():134416. PubMed ID: 31398456 [TBL] [Abstract][Full Text] [Related]
31. An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization. Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Shen L; Noda Y; Furukawa S; Nabeshima T Biol Psychiatry; 2007 Apr; 61(7):890-901. PubMed ID: 17046726 [TBL] [Abstract][Full Text] [Related]
32. Netrin-1 receptor-deficient mice show age-specific impairment in drug-induced locomotor hyperactivity but still self-administer methamphetamine. Kim JH; Lavan D; Chen N; Flores C; Cooper H; Lawrence AJ Psychopharmacology (Berl); 2013 Dec; 230(4):607-16. PubMed ID: 23820928 [TBL] [Abstract][Full Text] [Related]
33. The role of the laterodorsal tegmental nucleus in methamphetamine conditioned place preference and locomotor activity. Dobbs LK; Cunningham CL Behav Brain Res; 2014 May; 265():198-202. PubMed ID: 24569009 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms underlying microRNA-222-3p modulation of methamphetamine-induced conditioned place preference in the nucleus accumbens in mice. Shang Q; Wang J; Xi Z; Gao B; Qian H; An R; Shao G; Liu H; Li T; Liu X Psychopharmacology (Berl); 2022 Sep; 239(9):2997-3008. PubMed ID: 35881147 [TBL] [Abstract][Full Text] [Related]
35. Differential Roles of Intra-accumbal Orexin Receptors in Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference in the Rats. Khosrowabadi E; Karimi-Haghighi S; Jamali S; Haghparast A Neurochem Res; 2020 Sep; 45(9):2230-2241. PubMed ID: 32643036 [TBL] [Abstract][Full Text] [Related]
36. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. Miller DB; O'Callaghan JP; Ali SF Ann N Y Acad Sci; 2000 Sep; 914():194-207. PubMed ID: 11085321 [TBL] [Abstract][Full Text] [Related]
37. Effect of acute and chronic restraint stress on electrical activity of prefrontal cortex neurons in the reinstatement of extinguished methamphetamine-induced conditioned place preference: An electrophysiological study. Taslimi Z; Komaki A; Sarihi A; Haghparast A Brain Res Bull; 2019 Mar; 146():237-243. PubMed ID: 30660715 [TBL] [Abstract][Full Text] [Related]
38. The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice. Fujita Y; Kunitachi S; Iyo M; Hashimoto K Pharmacol Biochem Behav; 2012 Apr; 101(2):303-6. PubMed ID: 22260872 [TBL] [Abstract][Full Text] [Related]
39. Involvement of metabotropic glutamate receptor 5 in the inhibition of methamphetamine-associated contextual memory after prolonged extinction training. Huang CH; Yu YJ; Chang CH; Gean PW J Neurochem; 2016 Apr; 137(2):216-25. PubMed ID: 26748780 [TBL] [Abstract][Full Text] [Related]
40. Environmental enrichment does not reduce the rewarding and neurotoxic effects of methamphetamine. Thiriet N; Gennequin B; Lardeux V; Chauvet C; Decressac M; Janet T; Jaber M; Solinas M Neurotox Res; 2011 Jan; 19(1):172-82. PubMed ID: 20143198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]